Celltrion
068270.KS
#935
Rank
HK$207.95 B
Marketcap
HK$906.80
Share price
2.98%
Change (1 day)
-2.37%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

ESG Reports

Thumbnail Celltrion
 ESG Report 2024-2025

ESG Report 2024-2025

Language: English

View ESG Report
Thumbnail Celltrion
 ESG Report 2023-2024

ESG Report 2023-2024

Language: English

View ESG Report
Thumbnail Celltrion
 ESG Report 2022-2023

ESG Report 2022-2023

Language: English

View ESG Report